Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer

✍ Scribed by John Pippen; Devchand Paul; Svetislava Vukelja; Alicia Clawson; Jose Iglesias

• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 417 KB
• Volume: 130
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1678-9